No Tax Breaks for Drug Ads Act

HR 9021, the "No Tax Breaks for Drug Ads Act," prohibits pharmaceutical companies from deducting expenses related to direct-to-consumer advertising of prescription drugs when calculating their federal taxable income. This applies specifically to ads targeting the general public through media like TV, radio, print, social media, and digital platforms, but excludes ads directed at healthcare professionals. The bill directly affects drug manufacturers that spend on such consumer-facing advertising campaigns. The provision takes effect for expenses paid after the bill's enactment date.